Combined inhibition of BET family proteins and histone deacetylases as a potential epigenetics-based therapy for pancreatic ductal adenocarcinoma

Combined inhibition of BET family proteins and histone deacetylases as a potential epigenetics-based therapy for pancreatic ductal adenocarcinoma

Pancreatic ductal adenocarcinoma (PDAC) is one of the most lethal human cancers and shows resistance to any therapeutic strategy used. Here we tested small-molecule inhibitors targeting chromatin regulators as possible therapeutic agents in PDAC. We show that JQ1, an inhibitor of the bromodomain and...

Full description

Bibliographic Details
Main Authors: Mazur, Pawel K., Herner, Alexander, Mello, Stephano S., Wirth, Matthias, Hausmann, Simone, Lofgren, Shane M., Kuschma, Timo, Hahn, Stephan A., Vangala, Deepak, Trajkovic-Arsic, Marija, Gupta, Aayush, Heid, Irina, Noel, Peter B., Braren, Rickmer, Erkan, Mert, Kleeff, Jorg, Sipos, Bence, Sayles, Leanne C., Heikenwalder, Mathias, Hessmann, Elizabeth, Ellenrieder, Volker, Esposito, Irene, Bradner, James E., Khatri, Purvesh, Sweet-Cordero, E Alejandro, Attardi, Laura D., Schmid, Roland M., Schneider, Guenter, Sage, Julien, Siveke, Jens T., Sanchez-Rivera, Francisco Javier, Jacks, Tyler E.
Other Authors: Massachusetts Institute of Technology. Department of Biology
Format: Article
Language:en_US
Published: Nature Publishing Group 2017
Online Access:http://hdl.handle.net/1721.1/108655
https://orcid.org/0000-0001-5785-8911

Internet

http://hdl.handle.net/1721.1/108655
https://orcid.org/0000-0001-5785-8911

Similar Items